Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
75PHARMA Oy
OY
Active
Y-tunnus 0703322-7
Mikonkatu 9, 00100
Helsinki
All other professional, scientific and technical activities n.e.c.
·
NACE 7499
Est. 1988 · 38 years old
— employees
www.75pharmagroup.com
Share
Finland
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
75PHARMA Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
165
165
150
537
0
Staff expenses
−8
−8
−108
−160
−0
EBITDA
66
66
24
18
−204
Depreciation & amort.
−0
−0
−0
—
—
EBIT
66
66
24
18
−204
Net financials
−47
−47
−20
−11
−4
Profit before tax
18
18
4
7
−208
Tax
−0
−0
−0
3
−0
Net profit
18
18
4
4
−208
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
3 233
779
342
1 134
437
Equity
−204
−229
−247
−251
−255
Long-term debt
0
0
0
311
356
Short-term debt
3 436
1 008
589
1 074
336
Total debt
3 436
1 008
589
1 385
692
Financial ratios
5-year trend
EBITDA margin
40,1 %
This company
15,8 %
Market median
This company
Market median
154% above market
2021
2025
Equity ratio
−6,3 %
This company
38,2 %
Market median
This company
Market median
116% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin
11,2 %
This company
8,1 %
Market median
This company
Market median
38% above market
2021
2025
Asset turnover
0,05×
This company
1,12×
Market median
This company
Market median
96% below market
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on 75PHARMA Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
